Goodpasture syndrome surgery: Difference between revisions
Jump to navigation
Jump to search
Akshun Kalia (talk | contribs) No edit summary |
Akshun Kalia (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Surgery is not the first-line treatment option for patients with Goodpasture syndrome. Renal transplantation is usually reserved for patients who present with undetectable circulating anti-glomerular basement | Surgery is not the first-line treatment option for patients with Goodpasture syndrome. [[Renal transplantation]] is usually reserved for patients who present with undetectable circulating [[Anti-glomerular basement membrane antibody|anti-glomerular basement antibodie]]<nowiki/>s in serum for 12 months and atleast 6 months after stopping the use of [[cytotoxic]] agents. | ||
==Surgery== | ==Surgery== | ||
Revision as of 15:14, 1 May 2018
|
Goodpasture syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Goodpasture syndrome surgery On the Web |
|
American Roentgen Ray Society Images of Goodpasture syndrome surgery |
|
Risk calculators and risk factors for Goodpasture syndrome surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3] Akshun Kalia M.B.B.S.[4]
Overview
Surgery is not the first-line treatment option for patients with Goodpasture syndrome. Renal transplantation is usually reserved for patients who present with undetectable circulating anti-glomerular basement antibodies in serum for 12 months and atleast 6 months after stopping the use of cytotoxic agents.
Surgery
- Surgical intervention in the form of renal transplantation is indicated in patients with end-stage renal disease.
- Renal transplantation may be preformed when anti-glomerular basement membranes are undetectable for 6 months with no signs of pulmonary involvement.[1][2][3]
References
- ↑ Menn-Josephy H, Beck LH (2015). "Recurrent glomerular disease in the kidney allograft". Front Biosci (Elite Ed). 7: 135–48. PMID 25553369.
- ↑ "Notice". Kidney Int Suppl (2011). 2 (2): 139. 2012. doi:10.1038/kisup.2012.9. PMC 4089568. PMID 25028634.
- ↑ Chen M, Kallenberg CG (2010). "ANCA-associated vasculitides--advances in pathogenesis and treatment". Nat Rev Rheumatol. 6 (11): 653–64. doi:10.1038/nrrheum.2010.158. PMID 20924413.